A
AMRX icon

AlphaQuest’s Amneal Pharmaceuticals AMRX Stock Holding History

AlphaQuest’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-66,197
Closed -$834K – 116
2025
Q4 		$834K Sell
66,197
-22,364
-25% -$256K 0.05% 523
2025
Q3 		$886K Buy
88,561
+38,858
+78% +$349K 0.06% 482
2025
Q2 		$402K Buy
49,703
+49,305
+12,388% +$372K 0.04% 724
2025
Q1 		$3.33K Sell
398
-157,225
-100% -$1.31M ﹤0.01% 1883
2024
Q4 		$1.25M Buy
157,623
+147,537
+1,463% +$1.24M 0.17% 171
2024
Q3 		$83.9K Buy
+10,086
New +$78.9K 0.01% 1322

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AlphaQuest's AMRX Position: Q1 2026 in Review

AlphaQuest sold out of Amneal Pharmaceuticals (AMRX) in Q1 2026, closing a stake of 66,197 shares — an estimated $834K sold.

AlphaQuest first reported a position in AMRX in Q3 2024 and held it in 6 quarters. The position peaked at $1.25M in Q4 2024. 316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • AlphaQuest reported no remaining Amneal Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 66,197 Amneal Pharmaceuticals shares in Q1 2026, an estimated $834K.
  • AlphaQuest first reported a position in Amneal Pharmaceuticals in Q3 2024 and held it in 6 quarters.
  • AlphaQuest's Amneal Pharmaceuticals position peaked at $1.25M in Q4 2024.
  • 316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.